First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - CLARGES PHARMACEUTICALS LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: CLARGES PHARMACEUTICALS LIMITED, C/O Bdo Llp 5 Temple Square, Temple Street, Liverpool, L2 5RH. The legal status is a Private Limited Company and the current status at the registry of companies is Dissolved. The last filed accounts are dated 31 December 2020. The company was incorporated on 9 December 1908.

The accounts next due date is 30 September 2022. There are no mortgages.

The above was based on public record information as at 12 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 00100583
Date Incorporated: 9 December 1908
Date Latest Accounts: 31 December 2020
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 00100583
Annual Return: 15 August 2015
Registered Office: C/O Bdo Llp 5 Temple Square, Temple Street, Liverpool, L2 5RH
SIC Code and Operations: 74990
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

CLARGES PHARMACEUTICALS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 22 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
01418508 CLARGES PHARMACEUTICALS TRUSTEES LIMITED Active
14646370 CLARGES PROFESSIONAL SERVICES LTD Active
15291435 CLARGES PROPERTY MANAGEMENT LTD Active
05969434 CLARGES RISE LTD Active
09619533 CLARGES SECURITIES LIMITED Dissolved

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd